Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

170.59
+3.962.38%
Post-market: 170.20-0.3900-0.23%17:36 EDT
Volume:976.21K
Turnover:165.63M
Market Cap:8.72B
PE:852.95
High:171.19
Open:167.50
Low:165.35
Close:166.63
Loading ...

Charles River Laboratories International Inc - Amends and Restates Credit Agreement

THOMSON REUTERS
·
14 Dec 2024

Regeneron Down 15.5% Year to Date: How to Play the Stock?

Zacks
·
13 Dec 2024

Is There Now An Opportunity In Charles River Laboratories International, Inc. (NYSE:CRL)?

Simply Wall St.
·
11 Dec 2024

Market Today: Lululemon Surges, AMD Faces Demand Challenges, Apple Plans Modem Shift

GuruFocus
·
07 Dec 2024

Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report?

Zacks
·
07 Dec 2024

CRL Stock to Gain From the Global Biotech Incubator Program Launch

Zacks
·
06 Dec 2024

Charles River Introduces Global Biotech Incubator Program

Business Wire
·
05 Dec 2024

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

Zacks
·
04 Dec 2024

Charles River Laboratories to Present at Evercore ISI Investor Conference

Business Wire
·
02 Dec 2024

Applied Therapeutics Stock Plummets After FDA Rejects Metabolic Disease Drug

Investopedia
·
29 Nov 2024

Voyager rises after upgrade, Applied plunges after CRL: Morning Movers

TIPRANKS
·
29 Nov 2024

Applied Therapeutics CRL a ‘major setback,’ says William Blair

TIPRANKS
·
29 Nov 2024

At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?

Simply Wall St.
·
29 Nov 2024

OTLK Stock Falls on Failure to Meet Non-Inferiority Goal in AMD Study

Zacks
·
28 Nov 2024

APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA

Zacks
·
28 Nov 2024

French firm joins SBS Transit to win Jurong Region Line contract; first foreign operator in Singapore rail

CNA
·
28 Nov 2024